We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TSCO:LSETesco PLC Analysis

Data as of 2026-09-01 - not real-time

£471.50

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Tesco PLC is neutral at £471.50, with no clear ordering between short and long averages. Over a rolling month the price has lost 1.5%. Momentum indicators put RSI at 55.2 (neutral) with MACD reading bullish. The recent range runs from support at an unavailable price up to resistance at £487.90.
On valuation the read is fair — an earnings multiple of 17.5, absent a reliable peer benchmark. The average analyst target implies 9.0% above today's level. Revenue is growing at 7.2% on a 2.4% profit margin. The 3.17% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 21.7%, a beta of -0.07 and a maximum drawdown of 14.2%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.

Top Market Events

Marks and Spencer Group PLC LSE:MKS , Tesco PLC LSE:TSCO , and Associated British Foods PLC LSE:ABF faced divergent...Shares in Tesco PLC LSE:TSCO fell on Wednesday after Shore Capital downgraded Britain's largest supermarket group for...How have Tesco shares done over the past five years.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 460.71
  • MACD momentum is positive
  • RSI at 55.2 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 460.71
  • Analyst targets imply +9.0% versus the current price
  • MACD momentum is positive

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +9.0% versus the current price
  • P/E ratio of 17.5
  • Return on equity of 15.5%

Key Metrics & Analysis

Financial Health

Revenue Growth7.20%
Profit Margin2.42%
P/E Ratio17.5
ROE15.46%
ROA4.93%
Debt/Equity131.62
P/B Ratio2.6
Op. Cash Flow£3.9B
Free Cash Flow£2.2B

Technical Analysis

TrendNeutral
RSI55.2
Support£0.00
Resistance£487.90
MA 20£461.68
MA 50£468.45
MA 200£460.71
MACDBullish
VolumeStable
Fear & Greed Index92.25

Valuation

Fair Value£446.39
Target Price£514.00
Upside/Downside9.01%
GradeFair
TypeBlend
Dividend Yield3.17%

Risk Assessment

Beta-0.07
Volatility21.74%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.